NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
First China-manufactured trastuzumab biosimilar HLX02 global phase 3 trial met primary endpoint in breast cancer outcomes...
Priscilla Lynch reports on the latest data on breast cancer incidence, treatment, and outcomes in Ireland...
Sandra Ryan provides an overview of this year’s Gathering around Cancer Conference, which was held in...
Approximately one-in-nine women in Ireland will develop breast cancer at some point in their lives, while...
Next month, the seventh Gathering Around Cancer conference takes place in Croke Park, Dublin. David Lynch...
Priscilla Lynch presents a round-up of the most important studies presented at the 2019 American Society...
No improvement in disease-free survival (DFS) with adjuvant pazopanib (a VEGF tyrosine kinase inhibitor) was observed...
Dr Dearbhaile Collins outlines the latest trial data on immunotherapies for cervical cancer The National Cancer...
The introduction of robotic surgery in GUH is a major benefit for prostate patients, writes Mr...
Ms Clare O’Connell and Mr Peter E Lonergan report on the highlights of the 2019 JFIGCC...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT